How to overcome sexual challenges after cancer.

Many who have undergone treatment for chemotherapy report they can’t think as clearly as they used to. Experts break down the phenomenon often known as “chemo brain.” 

Patients often find themselves juggling new financial worries at the same time as a cancer diagnosis. Now, researchers are tackling the issue.

Inhibition of STAT3 signaling may improve survival in those with H3.3G34R/V mutant gliomas, animal studies suggest.

What if a common diabetes medication could help fight a rare type of childhood brain cancer? Recent lab studies reveal metformin shows promising results in suppressing specific tumor types.

Researchers have found a common mutation in gliomas makes them sensitive to immunotherapy. Studies of mouse models indicate a potential path toward more effective treatments for this type of cancer.

The device, which takes measurements every two minutes, was able to detect infection and cytokine release syndrome events several hours sooner than routine monitoring.

Cell culture study maps mechanisms underlying a new potential strategy for killing pancreatic cancer cells through a type of cell death known as ferroptosis.

An analysis of patient data from across Michigan found scores from the Decipher Biopsy test independently aligned with outcomes.

Duke, who was profiled in March 2020, reflects on navigating life with stage 4 cancer while much of the country is focused on getting ‘back to normal’ 

A new blood test could give doctors more time to try alternative treatments for HPV-positive throat cancer by signaling whether initial treatment is effective much earlier than current diagnostic tests.

Activity of the polycomb repressive complex 1 is essential for the development and maintenance of leukemic cells; disrupting it presents a new potential therapeutic approach.

Some prostate tumors transition from being glandular to more nerve-like in response to drugs that block the androgen receptor; a new preclinical study examines the underlying mechanisms and uncovers a promising countermeasure.

The effort by the Michigan Radiation Oncology Quality Consortium reduced unnecessary medical procedures, and saved the time and resources of patients and families.

Trial will evaluate the safety and efficacy of histotripsy against liver tumors at eight U.S. sites